Sitemap

Merck donated 2.4 million RSD for medical and protective equipment in Serbia

More...

Interstate Agreement On Encouraging Investments Signed With The US

Minister of Finance Sinisa Mali and US...

The EQA. Electric athlete in compact format

EQA is the name of the new...

Air Serbia Partners With Booking.com And Rentalcars.com

Additional benefits for passengers of the Serbian...

News

The Serbian Government Adopted A Set Of Decrees In The Field Of The Economy For 2021

The Serbian government adopted a set of decrees in the field of the economy for 2021, which encourage regional...

TRAG Foundation Announces Fourteenth Competition Of The Virtus Award For Philanthropy

Trag Foundation has announced the launch of the competition for the 14th Annual VIRTUS Award for Philanthropy. This competition...

Novak Djokovic’s Open Letter After Facing Criticism For Quarantine Demands in Australia

World No 1 Novak Djokovic published an open letter to the Australian public on Twitter on Wednesday in which...

Joe Biden Inaugurated As The 46th President Of The United States

Joseph R Biden Jr has been sworn in as president of the United States and Kamala Harris has become...

COVID 19 Vaccination Drive In India

The commencement of COVID vaccinations has focused attention on the modern medical miracle of immunisation. It has eradicated some...

Globally Merck and the Jenner Institute developed a production platform that enables the mass production of a future vaccine. The joint team has reduced the development time of the production process from one year to two months.

“We have brought the future of vaccine production to the present,” said Merck’s executive board.

Merck, one of the world’s leading scientific and technological companies, has donated 2.4 million dinars to the Serbian health system, thus supporting the Government of Serbia’s efforts to address one of the biggest challenges faced today. The donation is realized in cooperation with UNICEF, it is intended for the procurement of medical and protective equipment for healthcare professionals, and today it was delivered in Serbia.

“We wanted to respond to what is currently most needed by the health care system in our country. Thanks to partners from UNICEF, we have directed assistance to the procurement of medical and protective equipment, currently essential for healthcare professionals, which is one of the priorities of the Ministry of Health. We want to thank all health care professionals for their commitment to protecting the health of the population,” said Ina Bulat, Merck’s CEO in Serbia.

UNICEF is fully supportive of national efforts to protect the population, primarily through the procurement of critically needed equipment for the health system. The number of companies and individuals who have responded to our call indicates that there is a strong awareness in Serbia that community is a force that can help us. I want to thank all the companies that donated to UNICEF to help us get rid of the coronary virus together and save lives in Serbia,” said Regina De Dominicis, Director of UNICEF in Serbia.

Merck is globally part of key initiatives to end the pandemic.

Merck and the Jenner Institute have announced that the foundation for mass production of Covid-19 ChAdOk1 nCoV-19 vaccine candidates has been laid. Over the last two years, Merck’s collaboration with the Jenner Institute has led to the development of a rapid platform that follows good manufacturing practices. The joint team reduced the production process development time from one year, as it would normally take, to just two months, thanks to a recently developed production platform.

Founded in November 2005 with the aim of developing innovative vaccines in partnership with Oxford University and the Pirbright Institute, the Jenner Institute has succeeded in developing Merck’s manufacturing process based on a previously generated platform, a key step in making the vaccine available as quickly as possible patients.

Also, on 26 March, Merck and the Bill & Melinda Gates Foundation, within a consortium of companies, announced an important collaboration to accelerate the development, production and delivery of vaccines, diagnostics and treatment for COVID-19.

In 2019, Merck was awarded the “Insight into the Future” prize of $1million for research into pandemic preparation, by Pardis Sabeti scientists at Harvard University and Broad and James Crow Institute at Vanderbilt University. With their teams, today, thanks to the Merck Award, they are working to identify the diagnosis and treatment for COVID-19.

Related Articles

COVID 19 Vaccination Drive In India

The commencement of COVID vaccinations has focused attention on the modern medical miracle of immunisation. It has eradicated some diseases and is close to...

Mass Vaccination At 18 Points Starts In Belgrade

Mass vaccination against the coronavirus started today in Belgrade at a total of 18 points, including the one at the Belgrade Fair, where more...

In Europe, Optimism And Reluctance As COVID Vaccines Arrive

There appears to be nearly as much skepticism of the vaccines that could eventually put an end to the coronavirus pandemic as there is...

Why Are So Many Serbian Doctors Dying Of COVID-19?

Serbia’s total death toll from coronavirus is relatively low, around 3,600, but its rate of fatalities in the medical profession is far higher than...

Tokyo’s Covid Outbreak Adds To Doubts Over Hosting Olympic Games

A dramatic rise in coronavirus cases in Tokyo has reignited speculation about the Olympic Games, which are due to open in the city in just...

EU Commission Concludes Exploratory Talks With Valneva To Secure A New Potential Vaccine

European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19. The envisaged contract with...

Preconditions For Beginning Of Mass Vaccination Provided

Prime Minister Ana Brnabic pointed out today that there will be enough vaccines available for all citizens who want to be vaccinated against coronavirus. During...

Commission Adopts €70 Million Package For Early Access To EU COVID-19 Vaccines In The Western Balkans

European Commission adopted a package of €70 million under the Instrument for Pre-Accession (IPA II) to help fund the access of Western Balkans partners...